loadpatents
name:-0.016073942184448
name:-0.0089371204376221
name:-0.00037789344787598
Mondoly; Nathalie Patent Filings

Mondoly; Nathalie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mondoly; Nathalie.The latest application filed is for "new therapeutical composition containing apomorphine as active ingredient".

Company Profile
0.9.19
  • Mondoly; Nathalie - Le Chesnay FR
  • Mondoly; Nathalie - LeChesnay FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
New Therapeutical Composition Containing Apomorphine As Active Ingredient
App 20210244724 - Dey; Michael ;   et al.
2021-08-12
Therapeutical composition containing apomorphine as active ingredient
Grant 11,026,938 - Dey , et al. June 8, 2
2021-06-08
Therapeutical Composition Containing Apomorphine As Active Ingredient
App 20180098981 - DEY; Michael ;   et al.
2018-04-12
Aqueous Gelling Compositions Of Soluble Active Pharmaceutical Peptides Providing Modified Release
App 20170035884 - Baronnet; Marie-Madeleine ;   et al.
2017-02-09
Clay compositions
Grant 9,511,023 - Hacher , et al. December 6, 2
2016-12-06
Therapeutical Composition Containing Apomorphine As Active Ingredient
App 20160310480 - Dey; Michael ;   et al.
2016-10-27
Sustained-release composition containing peptides as active ingredient
Grant 9,415,012 - Richard , et al. August 16, 2
2016-08-16
Aqueous Gelling Compositions of Soluble Active Pharmaceutical Peptides Providing Modified Release
App 20150157719 - Baronnet; Marie-Madeleine ;   et al.
2015-06-11
Method of drug delivery for bone anabolic protein
Grant 8,748,382 - Dey , et al. June 10, 2
2014-06-10
Sustained-release Composition Containing Peptides As Active Ingredient
App 20140127303 - Richard; Joel ;   et al.
2014-05-08
New Therapeutical Composition Containing Apomorphine As Active Ingredient
App 20140128422 - Dey; Michael ;   et al.
2014-05-08
Solid Pharmaceutical Composition Containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl Sulfamate And Polymorphs Thereof
App 20140056977 - MONDOLY; Nathalie ;   et al.
2014-02-27
Method Of Drug Delivery For Bone Anabolic Protein
App 20130157955 - Dey; Michael J. ;   et al.
2013-06-20
Clay Compositions
App 20130059016 - Hacher; Beatrice ;   et al.
2013-03-07
Solid Pharmaceutical Composition Containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl Sulfamate And Polymorphs Thereof
App 20120321714 - MONDOLY; Nathalie ;   et al.
2012-12-20
Stable composition comprising a PTHrP analogue
Grant 8,148,333 - Dey , et al. April 3, 2
2012-04-03
Glp-1 Analogues Pharmaceutical Compositions
App 20120077746 - Mondoly; Nathalie ;   et al.
2012-03-29
Method Of Drug Delivery For Bone Anabolic Protein
App 20110092425 - Dey; Michael J. ;   et al.
2011-04-21
Method of treating osteoporosis comprising administration of PTHrP analog
Grant 7,803,770 - Dey , et al. September 28, 2
2010-09-28
Stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof
App 20100029556 - Dey; Michael J. ;   et al.
2010-02-04
Method of drug delivery for bone anabolic protein
App 20090227498 - Dey; Michael J. ;   et al.
2009-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed